Business Description
Columbia Banking System, Inc. serves as the parent organization for Columbia State Bank, which delivers a wide array of banking services to individuals, professionals, and small to medium-sized businesses across the United States. For personal clients, the bank provides diverse deposit accounts, including interest-bearing and non-interest checking, savings, money market, and certificates of deposit. Its lending products feature home mortgages for purchases and refinances, home equity loans and lines of credit, and other personal loan options. Customers also have access to debit and credit cards, along with comprehensive digital banking solutions. Business clients benefit from services such as checking, savings, interest-bearing money market, and certificate of deposit accounts. The company offers a variety of commercial loans, including agricultural, asset-based, builder, and commercial real estate financing, in addition to Small Business Administration (SBA)-guaranteed loans. Further business support includes professional banking, treasury management, merchant card processing, and international banking services. The company also offers wealth management solutions tailored for individuals, families, and professional businesses. These include financial planning services covering asset allocation, net worth analysis, estate planning and preservation, education funding, and wealth transfer. Insurance options such as long-term care, life, and disability are available. Individual retirement solutions encompass planning, income strategies, and Traditional/Roth IRAs, while business solutions include retirement plans, key person insurance, succession planning, and deferred compensation. Furthermore, Columbia Banking System provides fiduciary, investment, and administrative trust services. These specialized offerings include personal and special needs trusts, estate settlement, investment agency, and charitable management. The bank maintains a physical presence through a network of 153 branch locations, with 68 situated in Washington, 59 in Oregon, 15 in Idaho, and 11 in California. Founded in 1993, the company is headquartered in Tacoma, Washington.
Business History
Generated: Jun 19, 2026 3:02amPrice Overview
Last updated: Jun 19, 2026 3:00am (8d ago)Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 2.31
Total Equity: $7.84B
Shares: 296,760,000
Total Debt: $3.89B
Cash: $511.00M
EBITDA: $895.31M
Total Debt: $3.89B
Cash: $511.00M
Revenue: $3.21B
Revenue: $3.21B
Revenue: $3.21B
Total Equity: $7.84B
Tax Rate: 24.5%
Equity: $7.84B
Total Debt: $3.89B
Cash: $511.00M
Current Liabilities: $3.45B
Long-Term Debt: $435.00M
Total Debt: $3.89B
Total Equity: $7.84B
Shares: 296,760,000
Shares: 296,760,000
CapEx: -$40.00M
Shares: 296,760,000
Stock Price: $30.55
Net Income: $550.03M
Industry Benchmarks
Advanced Analysis Forensic deep-dive · three lenses
Columbia Banking System is a mature regional bank that does generate real cash — FCF of $706M on $3.21B of revenue in the latest year, OCF/NI of 1.85x, accruals of -0.9% of assets, and a Beneish M of -3.24 all point to clean earnings. Revenue has more than doubled from $1.32B (2021) to $3.21B (2025) and net income recovered from a $337M trough in 2022 to $550M, with operating margin rebuilding to 23.4%. By the accounting integrity lens, this is a well-behaved bank.
The problem is per-share value. Diluted shares went from 219.6M (2021) to 195.9M (2023) — buybacks were working — then exploded to 296.8M in 2025, a 7.8% CAGR overall and roughly +50% in two years. That pattern, combined with the 2023 revenue step-up from $1.35B to $2.74B, is the fingerprint of a stock-funded merger (the Umpqua combination). So while aggregate earnings rose ~30% from 2022 to 2025, EPS on the new share count is materially diluted. The 223% buyback/SBC ratio is misleading because actual share-issuance was for M&A, not comp.
Balance sheet flags are partly artifacts of bank accounting — Altman Z of 0.11 and 'short-term debt > cash' are normal for deposit-taking institutions, not distress signals in the industrial sense. Insider tape is neutral-to-mildly-negative: zero open-market buys, small S-sales, mostly routine A-awards and F-inkind tax withholding. Nothing screams conviction from management.
Verify before trusting this (6)
- Confirm the 2023 share-count step-up and the 2025 jump to 296.8M diluted shares trace to the Umpqua merger and any follow-on capital raises, not ongoing equity funding needs.
- Net interest margin trend, deposit beta, and uninsured deposit % — the real risk metrics for a bank, which Altman Z does not capture.
- Credit quality: NPL ratio, allowance/loans, and CRE/office concentration in the loan book.
- CET1 and tangible book value per share trajectory through the merger — the true per-share value test for a bank.
- Whether the $3.45B short-term debt is FHLB advances/brokered deposits (normal funding) vs. distressed borrowing.
- Integration synergies actually realized vs. promised from the Umpqua deal, and any further M&A intent.
The e2e composite fair value of $35.23 implies roughly 15% upside from $30.55, which is a genuine but unremarkable margin of safety for a regional bank carrying post-merger integration risk. Earnings quality is clean (no haircut warranted), so the deserved value doesn't need to be marked down on accruals — but the ~50% share count expansion from M&A is a real per-share value leak that argues against pushing deserved value above the composite. Net, deserved value lands in the low-to-mid $30s.
The bear case — that regional banks are structurally repriced post-SVB and trade at discounts to book for a reason — is largely in the price; this isn't priced for perfection. The bull case requires merger synergies to actually materialize and no further equity issuance. At ~$30.55, you're paid a modest discount to wait, but not enough to call this a screaming bargain. It's a 'modestly cheap, fairly understood' situation — closer to fair than to deep value.
Verify before trusting this (5)
- Confirmation that management is done issuing equity for M&A — any further share issuance lowers deserved per-share value
- Realized merger cost synergies vs guidance in next 2-3 quarterly transcripts
- Net interest margin trajectory and deposit cost trends
- Credit quality / NPL trends in CRE book given regional bank cycle risk
- Tangible book value per share growth post-merger — the real per-share value test
COLB sits in the dead zone of sentiment: there is no live story pulling it up and no acute panic dragging it down. The tape is neutral (regime score +11, VIX 17), and with a 0.68 beta this name is structurally insulated from broad risk-off swings. The active narrative is a 'steady compounder' at minimal intensity with low cult coefficient - meaning almost no marginal buyer is showing up for the story, but almost no marginal seller is dumping it on a story break either. Where the pressure does exist, it is the lingering post-SVB regional-bank discount: the market has repriced the cohort and is not in a hurry to re-rate it, which caps multiple expansion absent a catalyst. Analyst tone is mildly constructive (10 Buys vs 9 Holds, target $33.63, ~8% above spot) but stale - zero revisions this month signals indifference rather than conviction, and that flat tone is itself a soft headwind because it gives no fuel for re-rating. Macro cross-currents are mixed for a regional bank: a 4.46% 10y with a barely-positive curve (0.27) is unhelpful for NIM narrative, but the absence of fresh regional-bank stress headlines means the bear story is dormant. Net: forces roughly cancel, with a slight lean to headwind from sector stigma and analyst apathy.
None surfaced.
None surfaced.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
Last updated: Jun 19, 2026 3:06am (8d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $1.3B | $1.3B | $2.7B | $3.0B | $3.2B |
| Cost of Revenue | $-255,000 | $162.0M | $959.4M | $1.1B | $1.0B |
| Gross Profit | $1.3B | $1.2B | $1.8B | $1.8B | $2.2B |
| Operating Expenses | $760.5M | $735.0M | $1.3B | $1.1B | $1.4B |
| Operating Income | $558.2M | $450.6M | $471.2M | $718.8M | $751.3M |
| Net Income | $420.3M | $336.8M | $348.7M | $533.7M | $550.0M |
| EBITDA | $589.7M | $478.9M | $615.5M | $868.6M | $895.3M |
| EPS | $1.92 | $1.55 | $1.79 | $2.56 | $2.31 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 19, 2026 3:02am (8d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $2.8B | $1.3B | $2.2B | $1.9B | $511.0M |
| Total Current Assets | $8.3B | $6.2B | $12.7B | $3.7B | $743.0M |
| Total Assets | $30.6B | $31.8B | $52.2B | $51.6B | $67.2B |
| Current Liabilities | $27.1B | $27.4B | $41.9B | $42.0B | $3.5B |
| Long-Term Debt | $387.5M | $1.3B | $4.4B | $3.5B | $435.0M |
| Total Liabilities | $27.9B | $29.4B | $47.2B | $46.5B | $59.4B |
| Total Equity | $2.7B | $2.5B | $5.0B | $5.1B | $7.8B |
| Retained Earnings | -$697.3M | -$543.8M | -$467.6M | -$237.3M | -$26.0M |
Cash Flow (Annual)
Last updated: Jun 19, 2026 3:06am (8d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $662.7M | $1.1B | $669.8M | $658.9M | $746.0M |
| Capital Expenditure | -$15.5M | -$27.1M | $0 | -$35.7M | -$40.0M |
| Free Cash Flow | $647.2M | $1.0B | $669.8M | $623.2M | $706.0M |
| Acquisitions (net) | $10.8M | $0 | $274.6M | $0 | $874.0M |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | -$80.7M | -$4.2M | -$6.3M | -$5.7M | -$109.0M |
| Net Change in Cash | $188.4M | -$1.5B | $867.9M | -$284.3M | $502.0M |
Analyst Estimates (Annual)
Last updated: Jun 19, 2026 3:00am (8d ago)| Metric | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Revenue |
$2.3B $2.3B – $2.3B
|
$2.8B $2.8B – $2.8B
|
$2.9B $2.8B – $2.9B
|
$2.9B $2.9B – $2.9B
|
| EBITDA |
$727.2M $721.8M – $733.0M
|
$887.5M $884.3M – $894.6M
|
$914.3M $904.7M – $927.1M
|
$925.6M $924.5M – $926.7M
|
| Net Income |
$872.1M $862.0M – $882.2M
|
$907.7M $898.8M – $916.5M
|
$993.7M $958.2M – $1.0B
|
$1.1B $1.1B – $1.1B
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 19, 2026 3:06am (8d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +2.2% | +103.6% | +8.1% | +8.3% |
| Gross Profit Growth | -10.1% | +50.5% | +2.2% | +19.2% |
| Operating Income Growth | -19.3% | +4.6% | +52.5% | +4.5% |
| Net Income Growth | -19.9% | +3.6% | +53.0% | +3.1% |
| EBITDA Growth | -18.8% | +28.5% | +41.1% | +3.1% |
Insider Trading (Recent)
Last updated: Jun 19, 2026 3:05am (8d ago)All SEC Form 4 codes
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-15 | MACHUCA LUIS | A-Award | 563.00 | $0.00 | $0 |
| 2026-06-08 | Moore Devine David | S-Sale | 60.00 | $29.77 | $1,786 |
| 2026-06-08 | Moore Devine David | S-Sale | 3,812.00 | $29.78 | $113,502 |
| 2026-05-14 | Varnado Anddria | A-Award | 3,949.00 | $0.00 | $0 |
| 2026-05-14 | Terry Hilliard C. III | A-Award | 3,949.00 | $0.00 | $0 |
| 2026-05-14 | STUDENMUND JAYNIE M | A-Award | 3,949.00 | $0.00 | $0 |
| 2026-05-14 | SEATON ELIZABETH WHITEHEAD | A-Award | 3,949.00 | $0.00 | $0 |
| 2026-05-14 | SCHULTZ JOHN F | A-Award | 3,949.00 | $0.00 | $0 |
| 2026-05-14 | MITCHELL M CHRISTIAN | A-Award | 3,949.00 | $0.00 | $0 |
| 2026-05-14 | MACHUCA LUIS | A-Award | 3,949.00 | $0.00 | $0 |
| 2026-05-14 | Lund Randal Lee | A-Award | 3,949.00 | $0.00 | $0 |
| 2026-05-14 | Forrest Eric | A-Award | 3,949.00 | $0.00 | $0 |
| 2026-05-14 | Finkelstein Mark A | A-Award | 3,949.00 | $0.00 | $0 |
| 2026-04-15 | Lakely Brock | F-InKind | 396.00 | $29.10 | $11,524 |
| 2026-03-13 | BARUFFI KUMI YAMAMOTO | F-InKind | 937.00 | $26.23 | $24,578 |
| 2026-03-13 | Lakely Brock | F-InKind | 211.00 | $26.23 | $5,535 |
| 2026-03-16 | MACHUCA LUIS | A-Award | 659.00 | $0.00 | $0 |
| 2026-03-13 | Stein Clint | M-Exempt | 18,171.00 | $0.00 | $0 |
| 2026-03-13 | Stein Clint | M-Exempt | 18,171.00 | $26.23 | $476,625 |
| 2026-03-13 | Stein Clint | F-InKind | 7,151.00 | $26.23 | $187,571 |
Dividend History (Last 20)
Last updated: Jun 19, 2026 3:00am (8d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-05-29 | $0.37 | 2026-05-15 | 2026-05-29 | 2026-06-15 |
| 2026-02-27 | $0.37 | 2026-02-13 | 2026-02-27 | 2026-03-16 |
| 2025-11-28 | $0.37 | 2025-11-14 | 2025-11-28 | 2025-12-15 |
| 2025-08-29 | $0.36 | 2025-08-15 | 2025-08-29 | 2025-09-15 |
| 2025-05-30 | $0.36 | 2025-05-16 | 2025-05-30 | 2025-06-16 |
| 2025-02-28 | $0.36 | 2025-02-14 | 2025-02-28 | 2025-03-17 |
| 2024-11-29 | $0.36 | 2024-11-15 | 2024-11-29 | 2024-12-16 |
| 2024-08-23 | $0.36 | 2024-08-12 | 2024-08-23 | 2024-09-09 |
| 2024-05-23 | $0.36 | 2024-05-13 | 2024-05-24 | 2024-06-10 |
| 2024-02-22 | $0.36 | 2024-02-09 | 2024-02-23 | 2024-03-11 |
| 2023-11-22 | $0.36 | 2023-11-13 | 2023-11-24 | 2023-12-11 |
| 2023-08-24 | $0.36 | 2023-08-14 | 2023-08-25 | 2023-09-11 |
| 2023-05-30 | $0.36 | 2023-05-15 | 2023-05-31 | 2023-06-15 |
| 2023-02-03 | $0.30 | 2023-01-24 | 2023-02-06 | 2023-02-21 |
| 2022-10-14 | $0.30 | 2022-10-05 | 2022-10-17 | 2022-10-28 |
| 2022-08-02 | $0.30 | 2022-07-21 | 2022-08-03 | 2022-08-17 |
| 2022-05-03 | $0.30 | 2022-04-21 | 2022-05-04 | 2022-05-18 |
| 2022-02-01 | $0.30 | 2022-01-19 | 2022-02-02 | 2022-02-16 |
| 2021-10-12 | $0.30 | 2021-09-30 | 2021-10-13 | 2021-10-27 |
| 2021-08-10 | $0.28 | 2021-07-29 | 2021-08-11 | 2021-08-25 |
Narrative Economics
market-narrative step).
Delvantic AI Findings
Looking at the raw quarterlies first: revenue ramps from $740M (Q2'24) to $851M (Q1'26), a clean ~15% trajectory, but net income is wildly lumpy — $86.6M, $152.4M, $96.0M, $215.0M, $192.0M. Those two sub-$100M quarters (Q1'25 and Q3'25 at 12% and 11.8% margins versus ~22% in the good quarters) scream credit provisioning or merger-related charges, not normalized earnings power. TTM net income is roughly $655M; the $550M FY25 print plus the strong Q1'26 suggests run-rate EPS closer to $3.00-3.30, putting forward P/E around 9-10x, not the 13.5x trailing. That's cheap even for a regional. The 2023 revenue doubling ($1.35B → $2.74B) is the Umpqua merger — so 2024-2025 is integration noise, and 2026 Q1 ($851M revenue, 22.6% margin) is the first clean quarter of what the combined entity actually earns.
The synthesis verdict ("Disconnected from Fundamentals," implying undervalued) and the Market Forces verdict ("Market Headwinds, avoid") are in direct contradiction, and the synthesis is closer to right but for fuzzy reasons. P/B of 1.05 on a bank that just printed a 22.6% net margin quarter and generates a 4.06% dividend yield with $706M FCF against a $7.27B market cap (FCF yield ~9.7%) is not a disaster scenario — it's a bank the market refuses to re-rate post-SVB. ROE at 9.2% is mediocre but improving as the lumpy quarters roll off; if normalized ROE settles at 11-12% (plausible given Q4'25 and Q1'26 prints), 1.0x book is too cheap. The Market Forces claim of "inadequate interest coverage" is a category error for a bank — interest expense IS the cost of goods, not a solvency metric. I'd push back hard on that signal.
The contrarian case the models underweight: this is a Pacific Northwest commercial lender with meaningful CRE exposure right as office/multifamily refinancing waves hit through 2026-2027. The lumpy quarters may not be one-time integration charges — they may be early credit migration that management is smoothing via reserve releases in alternating quarters. The $511M cash position is thin relative to a $50B+ asset base, and the balance sheet section is missing total debt and equity entirely, which is a real data gap (not just an FMP tag issue). Insider activity is essentially all equity awards with one trivial sale — neutral, not bullish; nobody's buying with cash. The "accelerating quarterly trend" signal is partially an artifact of merger comp timing, not organic loan growth, which industry data suggests is running low-single-digits for PNW regionals.
Net read: I dissent from Market Forces and partially agree with the synthesis. At $30.55, COLB trades at ~1.05x book, ~9-10x forward earnings on normalized run-rate, with a covered 4.06% dividend and $706M FCF. Fair value on a re-rating to 1.25x book and 11x normalized EPS lands in the $36-40 range, ~20-30% upside plus the dividend. But the catalyst path is slow — you're paid 4% to wait for either (a) two more clean quarters proving integration is done and credit is contained, or (b) a Fed cutting cycle that re-rates the whole regional bank complex. The risk is CRE credit deterioration showing up in H2 2026, which would justify the current discount in retrospect. The narrative engine is right that this is anchored, prosaic, and unloved — which is exactly when regionals offer asymmetric returns, provided you size for the credit tail.
GPT Critique
From my independent analysis of Columbia Banking System, Inc., the key focus is on the significant revenue growth trajectory and the marked variability in net income. The revenue increase from $740.2M in Q2 2024 to $851.0M in Q1 2026 is notable, representing a 15% growth, yet the large fluctuations in net income, especially the notably low quarters Q1 and Q3 of 2025, suggest instability likely due to credit provisioning or merger-related expenses. The revenue jump in 2023 from $1.35B to $2.74B aligns with the acquisition of Umpqua, indicating that the recent quarters are transitional, reflecting integration challenges rather than organic profitability.
I agree with Opus's assessment of the valuation, particularly the assertion that Columbia is undervalued. Opus argues that the current P/E ratio is misleading due to transitional earnings, suggesting a forward P/E of 9-10x based on anticipated EPS of $3.00-3.30. This aligns with the bank's recent strong quarter (Q1 2026) showing a 22.6% margin, which suggests normalization post-acquisition. I concur that the market's reluctance to re-rate the stock post-SVB is a factor, and the current price reflects a disconnect from the fundamentals of a bank with a 9.7% FCF yield and stable dividend.
However, I diverge from Opus on the risk assessment. While Opus downplays the Market Forces' warning of "inadequate interest coverage" as a misinterpretation, I find the concern over credit quality and potential CRE exposure more pressing. The Pacific Northwest commercial lending focus, coupled with significant CRE exposure during a refinancing wave, poses a risk that could exacerbate if credit conditions worsen. The irregular income pattern might be an early indicator of underlying credit issues rather than just integration noise. Additionally, the thin cash position relative to the asset base underscores potential liquidity concerns that are not fully addressed by Opus's analysis.
A skeptic might argue that both analyses underestimate the systemic risks facing regional banks, particularly in a volatile interest rate environment and potential credit tightening. They would point to the bank's reliance on continued favorable economic conditions and successful integration of acquisitions to maintain current valuations. The absence of detailed balance sheet metrics like total debt and equity further complicates a comprehensive risk assessment.